Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter

More in Oncology

Bloomberg News reports that the FDA has issued a positive review of Roche‘s breast cancer drug Perjeta for early treatment. Perjeta is already on the market for use in women with advanced breast cancer. The FDA now announces that, “Roche’s...
Reuters reports that a new publication by the Institute of Medicine warns that the United States’ cancer care delivery system is “in crisis.” According to the report, “cancer treatment has grown so complex, many U.S. doctors...
NEW YORK (Reuters Health) – Among several different DNA-based quantitative polymerase chain reaction (qPCR) assays for detecting a critical JAK2 mutation in myeloproliferative neoplasms, one stands out as having the best performance, a European study...